Back
 JHRSS  Vol.6 No.4 , December 2018
Pecuniary Value of Disability-Adjusted-Life-Years in the Arab Maghreb Union in 2015
Abstract: This study bridges extant information gap on the pecuniary value of disability-adjusted-life-years (DALYs) lost in the Arab Maghreb Union (AMU). The DALYs lost in 2015 are converted into money using human capital (lost output) approach. The AMU total value of DALYs lost from all causes is the sum of each of the five country’s pecuniary value of DALYs (PVD) lost from all causes. The PVD associated with DALYs lost due to jth disease among persons of a specific age group is the product of the per capita non-health GDP in international dollars (Int$) and the total DALYs lost. The 27,175,610 DALYs lost in AMU in 2015 had a pecuniary value of Int$ 289,033,271,814, which is equivalent to 25.6% the sub-region’s 2015 GDP. The average pecuniary value per DALY lost was Int$ 10,636, which ranged from a minimum of Int$ 4226 in Mauritania to a maximum of Int$ 13,852 in Algeria. The pecuniary value of DALYs lost from all causes in the AMU sub-region annually is substantive.
Cite this paper: Muthuri, R. , Muthuri, N. and Kirigia, J. (2018) Pecuniary Value of Disability-Adjusted-Life-Years in the Arab Maghreb Union in 2015. Journal of Human Resource and Sustainability Studies, 6, 249-274. doi: 10.4236/jhrss.2018.64041.
References

[1]   World Health Organization (WHO) (2017) World Health Statistics 2017: Monitoring Health for the SDGs, Sustainable Development Goals. WHO, Geneva.

[2]   International Pecuniary Fund (IMF) (2017) World Economic Outlook Database, October 2015. IMF, Washington DC.
http://www.imf.org/external/pubs/ft/weo/2015/02/weodata/weoselgr.aspx

[3]   WHO (2015) World Health Statistics 2015. WHO, Geneva.

[4]   WHO (2017) Global Health Expenditure Database. WHO, Geneva.
http://apps.who.int/nha/database/Select/Indicators/en

[5]   Stenberg, K., Hanssen, O., Edejer, T.T., Bertram, M., Brindley, C., Meshreky, A., Rosen, J.E., Stover, J., Verboom, P., Sanders, R. and Soucat, A. (2017) Financing Transformative Health Systems towards Achievement of the Health Sustainable Development Goals: A Model for Projected Resource Needs in 67 Low-Income and Middle-Income Countries. Lancet Global Health, 5, e875-e887.
https://doi.org/10.1016/S2214-109X(17)30263-2

[6]   Public Health Agency of Canada (2014) Economic Burden of Illness in Canada, 2005-2008. Ministry of Health, Toronto.

[7]   Rice, D.P. (1967) Estimating the Cost of Illness. American Journal of Public Health and the Nation’s Health, 57, 424-440.
https://doi.org/10.2105/AJPH.57.3.424

[8]   Brown, M.L., Lipscomb, J. and Snyder, C. (2001) The Burden of Illness of Cancer: Economic Cost and Quality of Life. Annual Review of Public Health, 22, 91-113.
https://doi.org/10.1146/annurev.publhealth.22.1.91

[9]   Rice, D.P., Hodgson, T.A. and Kopstein, A.N. (1985) The Economic Costs of Illness: a Replication and Update. Health Care Financing Review, 7, 61-70.

[10]   Myers, R.P., Krajden, M., Bilodeau, M., Kaita, K., Marotta, P., Ramji, A., Estes, C., Razavi, H. and Sherman, M. (2014), Burden of Disease and Cost of Chronic Hepatitis C Infection in Canada. Canadian Journal of Gastroenterology and Hepatology, 28, 243-250.
https://doi.org/10.1155/2014/317623

[11]   Bradley, C., Yabroff, K.R., Dahman, B., Feuer, E.J., Mariotto, A. and Brown, M. (2008) Productivity Costs of Cancer Mortality in the United States: 2000-2020. Journal of National Cancer Institute, 100, 1763-1770.
https://doi.org/10.1093/jnci/djn384

[12]   Liu, J.L., Maniadakis, N., Gray, A. and Rayner, M. (2002) The Economic Burden of Coronary Heart Disease in the UK. Heart, 88, 597-603.
https://doi.org/10.1136/heart.88.6.597

[13]   Fineberg, N.A., Haddad, P.M., Carpenter, L., Gannon, B., Sharpe, R., Young, A.H., Joyce, E., Rowe, J., Wellsted, D., Nutt, D.J. and Sahakian, B.J. (2013) The Size, Burden and Cost of Disorders of the Brain in the UK. Journal of Psychopharmacology, 27, 761-770.
https://doi.org/10.1177/0269881113495118

[14]   Leal, J., Luengo-Fernández, R., Gray, A., Petersen, S. and Rayner, M. (2006) Economic Burden of Cardiovascular Diseases in the Enlarged European Union. European Heart Journal, 27, 1610-1619.
https://doi.org/10.1093/eurheartj/ehi733

[15]   Luengo-Fernandez, R., Leal, J., Gray, A., Petersen, S. and Rayner, M. (2006) Cost of Cardiovascular Diseases in the United Kingdom. Heart, 92, 1384-1389.
https://doi.org/10.1136/hrt.2005.072173

[16]   Olesen, J., Gustavsson, A., Svensson, M., Wittchen, H.U. and Jonsson, B. (2012) The Economic Cost of Brain Disorders in Europe. European Journal of Neurology, 19, 155-162.
https://doi.org/10.1111/j.1468-1331.2011.03590.x

[17]   Shepard, D.S., Coudeville, L., Halasam, Y.A., Zambrano, B. and Dayan, G.H. (2011) Economic Impact of Dengue Illness in the Americas. The American Journal of Tropical Medicine and Hygiene, 84, 200-207.
https://doi.org/10.4269/ajtmh.2011.10-0503

[18]   Alam, K. and Mahal, A. (2014) The Economic Burden of Angina on Households in South Asia. BMC Public Health, 14, 179.
http://www.biomedcentral.com/1471-2458/14/179
https://doi.org/10.1186/1471-2458-14-179


[19]   Shepard, D.S., Undurraga, E.A. and Halasa, Y.A. (2013) Economic and Disease Burden of Dengue in Southeast Asia. PLOS Neglected Tropical Diseases, 7, e2055.
https://doi.org/10.1371/journal.pntd.0002055

[20]   Sakdapolrak, P., Seyler, T. and Ergler, C. (2013) Burden of Direct and Indirect Costs of Illness: Empirical Findings from Slum Settlements in Chennai, South India. Progress in Development Studies, 13, 135-151.
https://doi.org/10.1177/1464993412466506

[21]   Luh, D.-L., Liu, C.-C., Luo, Y.-R. and Chen, S.-C. (2018) Economic Cost and Burden of Dengue during Epidemics and Non-Epidemic Years in Taiwan. Journal of Infection and Public Health, 11, 215-223.
https://doi.org/10.1016/j.jiph.2017.07.021

[22]   Sapkota, D., Bista, B. and Adhikari, S.R. (2016) Economic Costs Associated with Motorbike Accidents in Kathmandu, Nepal. Frontiers in Public Health, 4, 273.
https://doi.org/10.3389/fpubh.2016.00273

[23]   Shepard, D.S., Undurraga, E.A. and Halasa, Y.A. (2013) Economic and Disease Burden of Dengue in Southeast Asia. PLoS Neglected Tropical Diseases, 7, e2055.
https://doi.org/10.1371/journal.pntd.0002055

[24]   Bloom, D.E., Chen, S., Kuhn, M., McGovern, M.E., Oxley, L. and Prettner, K. (2017) The Economic Burden of Chronic Diseases: Estimates and Projections for China, Japan, and South Korea. NBER Working Paper No. 23601. National Bureau of Economic Research, Cambridge.

[25]   Hayata, E., Seto, K., Haga, K., Kitazawa, T., Matsumoto, K., Morita, M. and Hasegawa, T. (2015) Cost of Illness of the Cervical Cancer of the Uterus in Japan—A Time Trend and Future Projections. BMC Health Services Research, 15, 104.
https://doi.org/10.1186/s12913-015-0776-5

[26]   Shepard, D.S., Undurraga, E.A., Lees, R.S., Halasa, Y.A., Lum, L.C. and Ng, C.W. (2012) Use of Multiple Data Sources to Estimate the Economic Cost of Dengue Illness in Malaysia. American Journal of Tropical Medicine and Hygiene, 87, 796-805.
https://doi.org/10.4269/ajtmh.2012.12-0019

[27]   Kitazawa, T., Matsumoto, K., Fujita, S., Seto, K., Wu, Y., Hirao, T. and Hasegawa, T. (2018) Cost of Illness of Non-Alcoholic Liver Cirrhosis in Japan: A Time Trend Analysis and Future Projections. Hepatology Research, 48, 113-216.
https://doi.org/10.1111/hepr.12913

[28]   Matsumoto, K., Wu, Y., Kitazawa, T., Fujita, S., Seto, K. and Hasegawa, T. (2018) Cost of Illness of Hepatocellular Carcinomain Japan: A Time Trend and Future Projections. PLoS ONE, 13, e0199188.
https://doi.org/10.1371/journal.pone.0199188

[29]   Barcelo, A., Aedo, C., Rajpathak, S. and Robles, S. (2003) The Cost of Diabetes in Latin America and the Caribbean. Bulletin of the World Health Organization, 81, 19-27.

[30]   Villarreal-Ríos, E., Salinas-Martínez, A.M. and Medina-Jáuregui, A. (2000) The Cost of Diabetes Mellitus and Its Impact on Health Spending in Mexico. Archives of Medical Research, 31, 511-514.
https://doi.org/10.1016/S0188-4409(00)00095-3

[31]   Laserna, A., Barahona-Correa, J., Baquero, L., Castañeda-Cardona, C. and Rosselli, D. (2018) Economic Impact of Dengue Fever in Latin America and the Caribbean: A Systematic Review. Revista Panamericana de Salud Pública, 42, e111.
https://doi.org/10.26633/RPSP.2018.111

[32]   Murrugarra, E. and Bonilla-Chacín, M.E. (2013) Economic Impact of NCDs in Latin America and the Caribbean. World Bank, Washington DC.

[33]   Wettstein, Z.S., Fleming, M., Chang, A.Y., Copenhaver, D.J., Wateska, A.R., Bartsch, S.M., Lee, B.Y. and Kulkarni, R.P. (2012) Total Economic Cost and Burden of Dengue in Nicaragua: 1996-2010. American Journal of Tropical Medicine and Hygiene, 87, 616-622.
https://doi.org/10.4269/ajtmh.2012.12-0146

[34]   Torres, J.R. and Castro, J.S. (2007) The Health and Economic Impact of Dengue in Latin America. Cadernos de Saúde Pública—Journal Reports, 23, S23-S31.
https://doi.org/10.1590/S0102-311X2007001300004

[35]   United Nations Development Programme (UNDP) (2017) A Socio-Economic Impact Assessment of the Zika Virus in Latin America and the Caribbean: With a Focus on Brazil, Colombia and Suriname. UNDP, New York.

[36]   Bloom, D.E., Chen, S. and McGovern, M.E. (2018) The Economic Burden of Non-Communicable Diseases and Mental Health Conditions: Results for Costa Rica, Jamaica, and Peru. Revista Panamericana de Salud Pública, 42, e18.

[37]   Kirigia, J.M. and Mburugu, G.N. (2017) The Pecuniary Value of Human Lives Lost Due to Neglected Tropical Diseases in Africa. Infectious Diseases of Poverty, 6, 165.

[38]   Kirigia, J.M., Muthuri, R.D.K., Nabyonga-Orem, J. and Kirigia, D.W. (2015) Counting the Cost of Child Mortality in the World Health Organization African Region. BMC Public Health, 15, 1103.
https://doi.org/10.1186/s12889-015-2465-z
http://www.biomedcentral.com/content/pdf/s12889-015-2465-z.pdf

[39]   Kirigia, J.M., Sambo, L.G., Yokouide, A., Soumbey-Alley, E., Muthuri, L.K. and Kirigia, D.G. (2009) Economic Burden of Cholera in the WHO African Region. BMC International Health and Human Rights, 9, 8.
https://doi.org/10.1186/1472-698X-9-8
http://www.biomedcentral.com/1472-698X/9/8

[40]   Kirigia, J.M., Sambo, H.B., Sambo, L.G. and Barry, S.P. (2009) Economic Burden of Diabetes Mellitus in the WHO African Region. BMC International Health and Human Rights, 9, 6.
http://www.biomedcentral.com/1472-698X/9/6
https://doi.org/10.1186/1472-698X-9-6


[41]   Kirigia, J.M., Sambo, L.G., Aldis, W. and Mwabu, G. (2004) Impact of Disaster-Related Mortality on Gross Domestic Product in the WHO African Region. BMC Emergency Medicine, 4, 1.
http://www.biomedcentral.com/1471-227X/4/1
https://doi.org/10.1186/1471-227X-4-1


[42]   Kirigia, J.M., Masiye, F., Kirigia, D.W. and Akweongo, P. (2015) Indirect Costs Associated with Deaths from the Ebola Virus Disease in West Africa. Infectious Diseases of Poverty, 4, 45.
http://www.idpjournal.com/content/4/1/45
https://doi.org/10.1186/s40249-015-0079-4


[43]   Kirigia, J.M., Sambo, L.G., Okorosobo, T. and Mwabu, G. (2002) Impact of HIV/AIDS on Gross Domestic Product (GDP) in the WHO African Region. African Journal of Health Sciences, 9, 27-39.

[44]   Haacker, M. (2002) The Economic Consequences of HIV/AIDS in Southern Africa. IMF Working Paper WP/02/38. IMF, Washington DC.

[45]   Sicuri, E., Vieta, A., Lindner, L., Constenla, D. and Sauboin, C. (2013) The Economic Costs of Malaria in Children in Three Sub-Saharan Countries: Ghana, Tanzania and Kenya. Malaria Journal, 12, 307.
https://doi.org/10.1186/1475-2875-12-307

[46]   Okorosobo, F., Mwabu, G., Orem, J.N. and Kirigia, J.M. (2011) Economic Burden of Malaria in Five Countries of Africa. European Journal of Business and Management, 3, 42-62.
http://www.iiste.org/Journals/index.php/EJBM/article/download/536/422

[47]   Orem, J.N., Kirigia, J.M., Azairwe, R., Zikusooka, C.M., Bataringaya, J. and Ogwang, P.O. (2012) Cost of Malaria Morbidity in Uganda. Journal of Economics and Sustainable Development, 3, 58-80.
http://www.iiste.org/Journals/index.php/JEDS/article/download/1176/1097

[48]   Orem, J.N., Kirigia, J.M., Azairwe, R., Kasirye, I. and Walker, O. (2012) Impact of Malaria Morbidity on Gross Domestic Product in Uganda. International Archives of Medicine, 5, 12.
http://www.intarchmed.com/content/5/1/12

[49]   Kirigia, J.M., Mwabu, G.M., Orem, J.N. and Muthuri, R.D.K. (2016) Indirect Cost of Maternal Deaths in the WHO African Region, 2013. International Journal of Social Economics, 43, 532-548.
https://doi.org/10.1186/1755-7682-5-12
https://doi.org/10.1108/IJSE-05-2014-0105

[50]   Kirigia, J.M., Mwabu, G.M., Orem, J.N. and Muthuri, R.D.K. (2014) Indirect Cost of Maternal Deaths in the WHO African Region in 2010. BMC Pregnancy and Childbirth, 14, 299.
http://www.biomedcentral.com/1471-2393/14/299
https://doi.org/10.1186/1471-2393-14-299


[51]   Kirigia, J.M. and Sambo, L.G. (2003) Cost of Mental and Behavioural Disorders in Kenya. Annals of General Hospital Psychiatry, 2, 7.
http://www.annals-general-psychiatry.com/content/pdf/1475-2832-2-7.pdf
https://doi.org/10.1186/1475-2832-2-7


[52]   Kirigia, J.M., Mwabu, G.M., M’Imunya, J.M., Muthuri, R.D.K., Nkanata, L.H.K. and Gitonga, E.B. (2017) Indirect Cost of Non-Communicable Diseases Deaths in the World Health Organization African Region. International Archives of Medicine, 10.
http://imedicalsociety.org/ojs/index.php/iam/article/view/2400/2057

[53]   Kirigia, J.M. and Muthuri, R.D.K. (2016) Productivity Losses Associated with Tuberculosis Deaths in the World Health Organization African Region. Infectious Diseases of Poverty, 5, 43.
https://doi.org/10.1186/s40249-016-0138-5
https://idpjournal.biomedcentral.com/articles/10.1186/s40249-016-0138-5

[54]   Umar, N.A., Fordham, R., Abubakar, I. and Bachmann, M. (2012) The Indirect Cost Due to Pulmonary Tuberculosis in Patients Receiving Treatment in Bauchi State—Nigeria. Cost Effectiveness and Resource Allocation, 10, 6.
http://www.resource-allocation.com/content/10/1/6
https://doi.org/10.1186/1478-7547-10-6


[55]   Boutayeb, W., Lamlili, M.E.N., Boutayeb, A. and Boutayeb, S. (2013) Estimation of Direct and Indirect Cost of Diabetes in Morocco. Journal of Biomedical Science and Engineering, 6, 732-738.
https://doi.org/10.4236/jbise.2013.67090

[56]   Croitoru, L. and Sarraf, M. (2017) Estimating the Health Cost of Air Pollution: The Case of Morocco. Journal of Environmental Protection, 8, 1087-1099.
https://doi.org/10.4236/jep.2017.810069

[57]   Majorowski, M.M., Carabin, H., Kilani, M. and Bensalah, A. (2005) Echinococcosis in Tunisia: A Cost Analysis. Transactions of the Royal Society of Medicine, 99, 268-278.
https://doi.org/10.1016/j.trstmh.2004.06.011

[58]   Bouame, M., Lahmar, M.A., Bouafia, M.T., Hammoudi, N., Chentir, M.T., Athmane, M.A., Kara, S., Trancart, M., Levent, Y., Cheynel, J. and Soualmi, R. (2018) Economic Burden of Thromboembolic and Hemorrhagic Complications in Non-Valvular Atrial Fibrillation in Algeria. Journal of Medical Economics, 11, 1-8.
https://doi.org/10.1080/13696998.2018.1527341

[59]   Fox-Rushby, J.A. and Hanson, K. (2001) Calculating and Presenting Disability Adjusted Life Years (DALYs) in Cost-Effectiveness Analysis. Health Policy and Planning, 16, 326-331.
https://doi.org/10.1093/heapol/16.3.326

[60]   WHO (2017) WHO Methods and Data Sources for Global Burden of Disease 2000-2015. Global Health Estimates Technical Paper WHO/HIS/HSI/GHE/2017.1. WHO, Geneva.

[61]   Mushkin, S.J. and Collings, F.A. (1959) Economic Costs of Disease and Injury. Public Health Reports, 74, 795-809.
https://doi.org/10.2307/4590578

[62]   Weisbrod, B.A. (1971) Costs and Benefits of Medical Research: A Case Study of Poliomyelitis. Journal of Political Economy, 79, 527-544.
https://doi.org/10.1086/259766

[63]   Murray, C.J.L. (1994) Quantifying the Burden of Disease: The Technical Basis for Disability-Adjusted Life Years. Bulletin of the World Health Organization, 72, 427-445.

[64]   Kirigia, J.M. and Mwabu, G.M. (2018) The Monetary Value of Disability-Adjusted-Life-Years Lost in the East African Community in 2015. Modern Economy, 9, 1360-1377.
https://doi.org/10.4236/me.2018.97087

[65]   UN (2015) Transforming Our World: The 2030 Agenda for Sustainable Development. Seventieth Session of the United Nations General Assembly Resolution A/RES/70/1. UN, New York.

[66]   WHO (2016) Global Health Sector Strategy on HIV 2016-2021: Towards Ending AIDS. The Sixty-Ninth World Health Assembly Document A69/31. WHO, Geneva.

[67]   WHO. Global Health Observatory.
http://www.who.int/healthinfo/global_burden_disease/estimates/en/

[68]   WHO (2015) Global Technical Strategy for Malaria 2016-2030. WHO, Geneva.

[69]   WHO (2015) The End TB Strategy. WHO, Geneva.

[70]   WHO (2016) Draft Global Vector Control Response at a Glance. WHO, Geneva.

[71]   UN (2010) Eliminating Preventable Maternal Mortality and Morbidity through the Empowerment of Women. Commission on the Status of Women Resolution E/CN.6/2010/L.6. UN, New York.

[72]   UN (2018) Preventable Maternal Mortality and Morbidity and Human Rights. Human Rights Council Resolution A/HRC/RES/33/18. UN, New York.

[73]   African Union (AU) (2016) Maputo Plan of Action 2016-2030 for the Operationalisation of the Continental Policy Framework for Sexual and Reproductive Health and Rights. AU, Addis Ababa.

[74]   UN (2016) Political Declaration on HIV and AIDS: On the Fast Track to Accelerating the Fight against HIV and to Ending the AIDS Epidemic by 2030. Resolution A/RES/70/266. UN, New York.

[75]   UN (2011) Political Declaration on HIV and AIDS: Intensifying Our Efforts to Eliminate HIV and AIDS. Resolution A/RES/65/277. UN, New York.

[76]   UN (2016) Political Declaration of the High-Level Meeting of the General Assembly on Antimicrobial Resistance. Resolution A/RES/71/3. UN, New York.

[77]   UN (2018) Political Declaration on the Fight against Tuberculosis-United to End Tuberculosis: An Urgent Global Response to a Global Epidemic. UN, New York.

[78]   UN (2018) Consolidating Gains and Accelerating Efforts to Control and Eliminate Malaria in Developing Countries, Particularly in Africa, by 2030. Resolution A/RES/72/309. UN, New York.

[79]   UN (2010) Health, Morbidity, Mortality and Development. Resolution 2010/1. UN, New York.

[80]   Uniting to Combat NTDs (2012) London Declaration on Neglected Tropical Diseases. Ending the Neglect and Reaching 2020 Goals. Uniting to Combat NTDs, London.

[81]   UN (2012) Political Declaration of the High-Level Meeting of the General Assembly on the Prevention and Control of Non-Communicable Diseases. Resolution A/RES/66/2. UN, New York.

[82]   UN (2003) Global Road Safety Crisis. Resolution A/RES/57/309. UN, New York.

[83]   UN (2018) Improving Global Road Safety. Resolution A/RES/72/271. UN, New York.

 
 
Top